- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Access through your institution Buy or subscribe boxed-textRatain MJ _ et al_. (2006) Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic
renal cell carcinoma. _J Clin Oncol_ 24: 2505–2512 BACKGROUND This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe
to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF
Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact
customer support REFERENCES * Escudier B _ et al_. (2005) Randomized phase III trial of the Raf kinase and VEGFR inhibitor sorafenib (BAY 43-9006) in patients with advanced renal cell
carcinoma (RCC) [abstract]. _J Clin Oncol_ 23 (Suppl): 4510 Article Google Scholar Download references ACKNOWLEDGEMENTS The synopsis was written by Carol Lovegrove, Freelance Medical
Writer. AUTHOR INFORMATION Author notes * The Cleveland Clinic Foundation, Desk A100, 9500 Euclid Avenue, Cleveland, OH 44195, USA kleine@ccf.org AUTHORS AND AFFILIATIONS * EA Klein is Head
of the Section of Urologic Oncology, Glickman Urological Institute, and Professor of Surgery, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.,
Eric A Klein Authors * Eric A Klein View author publications You can also search for this author inPubMed Google Scholar ETHICS DECLARATIONS COMPETING INTERESTS The author declares no
competing financial interests. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Klein, E. Promise for patients with metastatic renal cell carcinoma. _Nat
Rev Urol_ 4, 72–73 (2007). https://doi.org/10.1038/ncpuro0704 Download citation * Received: 11 November 2006 * Accepted: 16 November 2006 * Issue Date: February 2007 * DOI:
https://doi.org/10.1038/ncpuro0704 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently
available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative